Standardizing the immunological measurement of advanced glycation endproducts using normal human serum
- 1 August 1997
- journal article
- research article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 207 (1) , 79-88
- https://doi.org/10.1016/s0022-1759(97)00110-5
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Antibacterial activity of lysozyme and lactoferrin is inhibited by binding of advanced glycation–modified proteins to a conserved motifNature Medicine, 1995
- Immunological quantification of advanced glycosylation end-products in the serum of patients on hemodialysis or CAPDKidney International, 1994
- Immunochemical detection of advanced glycation end products in renal cortex from STZ-induced diabetic ratDiabetes, 1993
- Crosslines A and B as candidates for the fluorophores in age- and diabetes-related cross-linked proteins, and their diacetates produced by Maillard reaction of α-N-acetyl-L-lysine withD-glucoseJournal of the Chemical Society, Chemical Communications, 1992
- Role of oxidative stress in development of complications in diabetesDiabetes, 1991
- Immunochemical approach to characterize advanced glycation end products of the Maillard reactionJournal of Biological Chemistry, 1991
- Production and characterization of antibodies to advanced glycation products on proteinsBiochemical and Biophysical Research Communications, 1989
- Novel pyrroles from sulfite-inhibited Maillard reactions: insight into the mechanism of inhibitionThe Journal of Organic Chemistry, 1988
- The measurement of relative antibody affinity by ELISA using thiocyanate elutionJournal of Immunological Methods, 1988
- 3-(D-Erythro-Trihydroxypropyl)-1-Neopentyl Pyrrole-2-Carboxaldehyde. A Novel Nonenzymatic Browning Product of GlucoseJournal of Carbohydrate Chemistry, 1987